Fosun Pharmaceutical announced that in order to meet the daily operating needs of the holding subsidiary Fuyun Health, Fuyun Health signed a supplementary agreement with the shareholders of the three parties to unify and renew shareholders' loans with a total principal amount of 80.79 million yuan. The maturity date after renewal is September 4, 2027, and the annual interest rate for the rollover period is still 3.2%. Among them, the Group provided loans of 457.809 million yuan, and the related party Fosun Hi-Tech provided 350.91 million yuan. There is no need to separately request approval from the company's board of directors or shareholders' meeting for this renewal. As of the announcement, the loans provided by the Japan Group to Fuyun Health have not been overdue.

Fosun Pharmaceutical announced that in order to meet the daily operating needs of the holding subsidiary Fuyun Health, Fuyun Health signed a supplementary agreement with the shareholders of the three parties to unify and renew shareholders' loans with a total principal amount of 80.79 million yuan. The maturity date after renewal is September 4, 2027, and the annual interest rate for the rollover period is still 3.2%. Among them, the Group provided loans of 457.809 million yuan, and the related party Fosun Hi-Tech provided 350.91 million yuan. There is no need to separately request approval from the company's board of directors or shareholders' meeting for this renewal. As of the announcement, the loans provided by the Japan Group to Fuyun Health have not been overdue.